Pediatric Endocrinology Diabetes and Metabolism
en POLSKI
eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2025
vol. 31
 
Share:
Share:
abstract:
Case report

Aldosterone synthase deficiency due to homozygous CYP11B2 pathogenic variant with coexisting celiac disease: A case study and literature review

Zuzanna Gawlik
1, 2
,
Konrad Kaleta
3
,
Martyna Wróblewska
3
,
Maria Szwarkowska
3
,
Ewelina Preizner-Rzucidło
4
,
Krystian Jażdżewski
5
,
Sebastian Wardak
5
,
Jerzy B. Starzyk
1, 2
,
Dominika M. Januś
1, 2

  1. Department of Pediatric and Adolescent Endocrinology, University Children Hospital in Krakow, Poland
  2. Department of Pediatric and Adolescent Endocrinology, Chair of Pediatrics, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland
  3. Students’ Scientific Group of Pediatric Auxology, Faculty of Medicine, Jagiellonian University Medical College, University Children's Hospital, Krakow, Poland
  4. Department of Genetics, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland
  5. MedGen, Medical Center, Warsaw, Poland
Pediatr Endocrinol Diabetes Metab 2025; 31 (3): 133-140
Online publish date: 2025/10/23
View full text Get citation
 
PlumX metrics:
Aldosterone is synthesized in the adrenal zona glomerulosa via the action of the mitochondrial cytochrome P450 enzyme aldosterone synthase (CYP11B2) through sequential enzyme reactions. Pathogenic variants in CYP11B2 result in corticosterone methyloxidase type I deficiency (CMO I), an orphan condition with a potentially lethal electrolyte imbalance in infancy. We report the unique occurrence of CMO I with celiac disease in the first genetically confirmed Polish case of CMO I; a 15-year-old female, diagnosed initially in the neonatal period because of severe hyponatremia, hyperkalemia, metabolic acidosis, and failure to thrive. The patient’s clinical course was complicated by protracted electrolyte abnormalities, poor weight gain, and eventual diagnosis of celiac disease, which temporally correlated with abnormal growth patterns. Extensive endocrine assessment, steroid profiling, and next-generation DNA sequencing revealed a homozygous pathogenic variant in CYP11B2 (c.1354G>A; p.Gly452Arg), confirming CMO type I.
keywords:

celiac disease, hyponatremia, aldosterone synthase, adrenal insufficiency, CYP11B2


Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.